Ministry of Health - Immunisation Update
Stocks of Fluarix Tetra, the funded quadrivalent influenza vaccine approved for children younger than 3 years of age, have run out – Influvac (trivalent) vaccine is now funded for eligible children in this age group. The Influvac (trivalent) dose for children aged under 3 years is 0.25mls (ie a half dose). This vaccine contains the WHO approved strains for the 2018 season - the same strains of influenza A as the quadrivalent vaccine, and one strain of influenza B. Children under 3 years of age who have not received influenza vaccine in previous years, and have received one dose of Fluarix Tetra this year, may be given Influvac (trivalent) for their second dose.